Partnerships for the Development of Universal Influenza Vaccines (R21/R33 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-20-003 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to support development of promising universal influenza vaccine candidates that protect against both influenza A and B viruses.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding